BerGenBio ASA

BerGenBio

This biopharmaceutical company develops selective AXL kinase inhibitors to treat aggressive cancers and respiratory diseases for patients with limited therapeutic options.

Mersana Therapeutics

This company develops antibody-drug conjugates to treat various cancers for healthcare providers and patients within the oncology sector.

Akanocure Pharmaceuticals

This company develops small molecule drugs targeting orphan and unmet needs in oncology for healthcare providers and patients.

AnaptysBio

The company develops antibody-based medicines for inflammatory diseases and cancer to be used by healthcare providers and pharmaceutical partners.

APIM Therapeutics AS

This clinical-stage biotechnology company develops peptide drugs targeting cellular stress responses to treat patients with advanced solid tumours and multiple cancers.

CrossBridge Bio

This company develops dual-payload antibody-drug conjugates to treat solid tumors for healthcare providers and pharmaceutical partners.

Acceleron Pharma

The company develops medicines and vaccines to treat oncology, infectious diseases, and respiratory conditions for patients and healthcare providers.

Mnemo Therapeutics

This biotechnology company develops cell therapies and an epigenetic antigen discovery platform to treat solid tumours and blood cancers for healthcare providers.